Correction: Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer.

MLA

Peng, Rui, et al. “Correction: Resistance to FGFR1-Targeted Therapy Leads to Autophagy via TAK1/AMPK Activation in Gastric Cancer.” Gastric Cancer, vol. 27, no. 3, May 2024, pp. 643–45. EBSCOhost, https://doi.org/10.1007/s10120-024-01489-3.

APA

Peng, R., Chen, Y., Wei, L., Li, G., Feng, D., Liu, S., Jiang, R., Zheng, S., & Chen, Y. (2024). Correction: Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer. Gastric Cancer, 27(3), 643–645. https://doi.org/10.1007/s10120-024-01489-3

Chicago

Peng, Rui, Yan Chen, Liangnian Wei, Gang Li, Dongju Feng, Siru Liu, Runqiu Jiang, Shaojiang Zheng, and Yun Chen. 2024. “Correction: Resistance to FGFR1-Targeted Therapy Leads to Autophagy via TAK1/AMPK Activation in Gastric Cancer.” Gastric Cancer 27 (3): 643–45. doi:10.1007/s10120-024-01489-3.